title: Severe postoperative hyperthermic syndrome after addition of tilidine/naloxone to duloxetine therapy.
authors.forename: Marco
authors.initials: M
authors.lastname: Vinetti
authors.forename: Thierry
authors.initials: T
authors.lastname: Duprez
authors.forename: Philippe
authors.initials: P
authors.lastname: Hantson
mesh_terms: D000368:Aged; D000700:Analgesics / Q000009:adverse effects*; D001921:Brain / Q000187:drug effects; D004347:Drug Interactions; D000068736:Duloxetine Hydrochloride; D005260:Female; D005334:Fever / Q000139:chemically induced*; D006801:Humans; D008279:Magnetic Resonance Imaging; D009270:Naloxone / Q000008:administration & dosage / Q000009:adverse effects*; D009292:Narcotic Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D009294:Narcotics / Q000008:administration & dosage / Q000009:adverse effects*; D059906:Neuroimaging; D011183:Postoperative Complications / Q000139:chemically induced*; D013876:Thiophenes / Q000009:adverse effects*; D013993:Tilidine / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000700:Analgesics; D009292:Narcotic Antagonists; D009294:Narcotics; D013876:Thiophenes; D009270:Naloxone; D000068736:Duloxetine Hydrochloride; D013993:Tilidine